{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:41:17Z","timestamp":1792633277207,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.idnow.2023.104766","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T12:14:01Z","timestamp":1691064841000},"page":"104766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk factors and prognostic significance of infection of totally implantable vascular access port in solid tumor patients: A prospective cohort study"],"prefix":"10.1016","volume":"53","author":[{"given":"Amaury","family":"Bailleul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Fulgencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2123-5012","authenticated-orcid":false,"given":"Sophie","family":"Vimont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Mordelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Lassel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4837-1068","authenticated-orcid":false,"given":"Nathana\u00ebl","family":"Lapidus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Quesnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5716-4239","authenticated-orcid":false,"given":"Marc","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2023.104766_b0005","first-page":"403","article-title":"Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial","volume":"398","author":"Moss","year":"2021","journal-title":"LancetLond Engl"},{"key":"10.1016\/j.idnow.2023.104766_b0010","unstructured":"Pr\u00e9vention des infections associ\u00e9es aux chambres \u00e0 cath\u00e9ter implantables pour acc\u00e8s veineux - SF2H 2012 [Internet]. [cited 2020 Mar 16]. Available from: https:\/\/www.sf2h.net\/wp-content\/uploads\/2013\/01\/SF2H_recommandations_prevention-des-IA-aux-chambres-a-catheter-implantables-pour-acces-veineux-2012.pdf."},{"key":"10.1016\/j.idnow.2023.104766_b0015","first-page":"81","article-title":"Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer","volume":"26","author":"Voog","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.idnow.2023.104766_b0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s002689900342","article-title":"Implantable Vascular Access Systems: Experience in 1500 Patients with Totally Implanted Central Venous Port Systems","volume":"22","author":"Kock","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.idnow.2023.104766_b0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.medmal.2008.11.004","article-title":"Incidence, pr\u00e9valence et facteurs de risque de survenue d\u2019une premi\u00e8re complication infectieuse sur chambres \u00e0 cath\u00e9ter implantables","volume":"39","author":"Crisinel","year":"2009","journal-title":"M\u00e9decine Mal Infect"},{"key":"10.1016\/j.idnow.2023.104766_b0030","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3348\/kjr.2014.15.4.494","article-title":"Incidence and Risk Factors of Infectious Complications Related to Implantable Venous-Access Ports","volume":"15","author":"Shim","year":"2014","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.idnow.2023.104766_b0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jvsv.2015.10.008","article-title":"Risk factors for infectious and noninfectious complications of totally implantable venous catheters in cancer patients","volume":"4","author":"Zerati","year":"2016","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.idnow.2023.104766_b0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12013-014-0443-1","article-title":"Infections Related to Totally Implantable Venous-Access Ports: Long-Term Experience in One Center","volume":"72","author":"Ji","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.idnow.2023.104766_b0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MD.0b013e318275ffe1","article-title":"Clinical Outcome After a Totally Implantable Venous Access Port-Related Infection in Cancer Patients: A Prospective Study and Review of the Literature","volume":"91","author":"Lebeaux","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.idnow.2023.104766_b0050","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.revmed.2010.06.014","article-title":"Complications infectieuses li\u00e9es aux chambres implantables : caract\u00e9ristiques et prise en charge","volume":"31","author":"Lebeaux","year":"2010","journal-title":"Rev M\u00e9decine Interne"},{"key":"10.1016\/j.idnow.2023.104766_b0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1129729818758999","article-title":"Infection of totally implantable venous access devices: A review of the literature","volume":"19","author":"Pinelli","year":"2018","journal-title":"J Vasc Access"},{"key":"10.1016\/j.idnow.2023.104766_b0060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/112972980400500407","article-title":"Complications and management of long-term central venous access catheters and ports","volume":"5","author":"Yildizeli","year":"2004","journal-title":"J Vasc Access"},{"key":"10.1016\/j.idnow.2023.104766_b0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/annonc\/mdm272","article-title":"Management of venous port systems in oncology: a review of current evidence","volume":"19","author":"Vescia","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.idnow.2023.104766_b0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1067\/mic.2003.29","article-title":"Evaluation of infectious complications of the implantable venous access system in a general oncologic population","volume":"31","author":"Chang","year":"2003","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idnow.2023.104766_b0075","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/cncr.22942","article-title":"Risk factors for early catheter-related infections in cancer patients","volume":"110","author":"Penel","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.idnow.2023.104766_b0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000151393","article-title":"Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients","volume":"74","author":"Samaras","year":"2008","journal-title":"Oncology"},{"key":"10.1016\/j.idnow.2023.104766_b0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10096-012-1728-1","article-title":"Is diabetes a risk factor for central venous access port-related bloodstream infection in oncological patients?","volume":"32","author":"Tour\u00e9","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"key":"10.1016\/j.idnow.2023.104766_b0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/annonc\/mds468","article-title":"Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients","volume":"24","author":"Chen","year":"2013","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.idnow.2023.104766_b0095","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jfma.2015.06.013","article-title":"Incidence and risk factors for central venous access port-related infection in Chinese cancer patients","volume":"114","author":"Wang","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.idnow.2023.104766_b0100","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.3748\/wjg.v26.i25.3517","volume":"26","author":"Zhang","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.idnow.2023.104766_b0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.medmal.2015.12.006","article-title":"Outcome of totally implantable venous-access port-related infections","volume":"46","author":"Vidal","year":"2016","journal-title":"M\u00e9decine Mal Infect"},{"key":"10.1016\/j.idnow.2023.104766_b0110","first-page":"883","article-title":"French legal approach to patient consent in clinical research","volume":"39","author":"Toulouse","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.idnow.2023.104766_b0115","unstructured":"French Society of Hospital Hygiene (SF2H). Guidelines: Prevention of TIVAP-related infections (Pr\u00e9vention des infections associ\u00e9es aux chambres \u00e0 cath\u00e9ter implantables pour acc\u00e8s veineux) [Internet]. 2012 [cited 2023 Jan 12]. Available from: https:\/\/www.sf2h.net\/publications\/prevention-infections-associees-aux-chambres-a-catheter-implantables-acces-veineux."},{"key":"10.1016\/j.idnow.2023.104766_b0120","unstructured":"Comit\u00e9 de l\u2019antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, European Committee on Antimicrobial Susceptibility Testing. Recommandations sur l\u2019antibiogramme - 2019 (V2.0 Mai) [Internet]. 2019 [cited 2023 Jul 17]. Available from: https:\/\/www.sfm-microbiologie.org\/wp-content\/uploads\/2019\/05\/CASFM2019_V2.0_MAI.pdf."},{"key":"10.1016\/j.idnow.2023.104766_b0125","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Soci\u00e9t\u00e9 Fran\u00e7aise de Mycologie M\u00e9dicale, Soci\u00e9t\u00e9 Fran\u00e7aise de Parasitologie. R\u00e9f\u00e9rentiel en microbiologie m\u00e9dicale (REMIC) - 6e \u00e9dition - 2018 [Internet]. 2018 [cited 2023 Jul 17]. Available from: https:\/\/www.sfm-microbiologie.org\/boutique\/referentiel-en-microbiologie-medicale-remic\/."},{"key":"10.1016\/j.idnow.2023.104766_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.idnow.2023.104766_b0135","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0895-4356(96)00025-X","article-title":"Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis","volume":"49","author":"Sun","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.idnow.2023.104766_b0140","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ejso.2016.10.020","volume":"43","author":"Kakkos","year":"2017","journal-title":"Eur J Surg Oncol EJSO"},{"key":"10.1016\/j.idnow.2023.104766_b0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1473-3099(13)70266-4","article-title":"Management of infections related to totally implantable venous-access ports: challenges and perspectives","volume":"14","author":"Lebeaux","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idnow.2023.104766_b0150","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1086\/501658","article-title":"Long-Term Central Venous Catheter Infection in HIV-infected and Cancer Patients: A Multicenter Cohort Study","volume":"20","author":"Astagneau","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idnow.2023.104766_b0155","first-page":"563","article-title":"Skin barrier function in patients under radiation therapy due to the head and neck cancers - Preliminary study","volume":"24","author":"Pazdrowski","year":"2019","journal-title":"Rep Pract Oncol Radiother J Gt Cancer Cent Poznan Pol Soc Radiat Oncol"},{"key":"10.1016\/j.idnow.2023.104766_b0160","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1742-481X.2008.00436.x","article-title":"Wound healing in radiated skin: pathophysiology and treatment options","volume":"5","author":"Olascoaga","year":"2008","journal-title":"Int Wound J"},{"key":"10.1016\/j.idnow.2023.104766_b0165","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ejso.2011.06.016","article-title":"Totally implantable venous access port systems and risk factors for complications: A one-year prospective study in a cancer centre","volume":"37","author":"Narducci","year":"2011","journal-title":"Eur J Surg Oncol EJSO"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991923001288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991923001288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:33:22Z","timestamp":1763019202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991923001288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2666991923001288"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2023.104766","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and prognostic significance of infection of totally implantable vascular access port in solid tumor patients: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2023.104766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104766"}}